DIAJARD FORTE XR 10/5/1000MG TAB

DIAJARD FORTE XR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 10mg, Linagliptin 5mg, and Metformin 1000mg—three potent antidiabetic agents working synergistically to control blood glucose levels. Empagliflozin helps your kidneys eliminate excess glucose through urine, while Linagliptin enhances insulin secretion and reduces glucagon levels. Metformin improves insulin sensitivity and decreases hepatic glucose production. This extended-release formulation ensures steady, sustained medication delivery throughout the day. Ideal for patients with type 2 diabetes requiring multi-drug therapy, DIAJARD FORTE XR simplifies treatment by combining three medications in one tablet, improving medication adherence and convenience. Consult your healthcare provider to determine if this combination is suitable for your diabetes management plan.